The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - AstraZeneca; AVEO; Bayer; Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer
 
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Novartis
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Novartis; Pfizer; Roche; Sanofi
Sequential treatment with pazopanib (PAZO) followed by nivolumab (NIVO) in patients with advanced or metastatic renal cell carcinoma (mRCC): Third interim results of the non-interventional study PAZOREAL.
 
Martin Boegemann
Honoraria - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen; MSD; Novartis; Roche
Consulting or Advisory Role - Advanced Biochemical Compounds; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen; MSD; Novartis; Roche
Research Funding - Janssen
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb; Janssen; Novartis
 
Jens Bedke
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; MSD; Nektar; Novartis; Roche
Speakers' Bureau - Eisai; EUSA Pharma; Ipsen; MSD; Novartis; Pfizer; Roche
 
Martin Schostak
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Novartis
Travel, Accommodations, Expenses - Novartis
 
Christiane Hering-Schubert
No Relationships to Disclose
 
Manfred Welslau
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer; Roche; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Lilly; Novartis; Pfizer
 
Jan Schleicher
Honoraria - Bayer; BioSyn GbH; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer
 
Thomas Wolf
No Relationships to Disclose
 
Alexander Petzoldt
No Relationships to Disclose
 
Christian Doehn
No Relationships to Disclose
 
Carsten Grüllich
Honoraria - Amgen; Bristol-Myers Squibb; Eisai; Ipsen; Janssen Oncology; MSD Oncology; Pfizer; Roche/Genentech; Sanofi/Aventis
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer; Roche/Genentech; Sanofi
Research Funding - Eisai; Ipsen
Travel, Accommodations, Expenses - Gilead Sciences; Ipsen; Novartis; Roche/Genentech
 
Viktor Grünwald
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; MSD
Honoraria - Ars tempi; AstraZeneca; Bayer; Bristol-Myers Squibb; Cerulean Pharma; COCS GmbH; Eisai; EUSA Pharma; Exelixis; Ipsen; Janssen-Cilag; Lilly; MedKom Akademie; Merck Serono; MSD Oncology; NewConceptOncology; Novartis; Pfizer; PharmaMar; Promedior; Roche; Update Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; Cerulean Pharma; ClinSol; Ipsen; Lilly; MSD Oncology; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Novartis (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Ipsen; MSD Oncology; Novartis; Pfizer
 
Thomas Steiner
Employment - Fresenius
 
Anja Rogler
Employment - Novartis
 
Sven Hanson
Employment - Novartis
 
Dunja Klein
Employment - iOMEDICO
Honoraria - iOMEDICO
 
Tanja Medinger
Employment - iOMEDICO
 
Peter-Juergen Goebell
No Relationships to Disclose